Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BiondVax Pharmaceuticals Ltd. BVXV

Set alert

Price alert · BVXV

All alert types
1.36 +1.36 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
4.93M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-0.59
Beta
2.38
Short ratio
0.03
Inst. own
0.02%
Dividend
0.00
Ex-div date
Earnings
Aug 11, 2023
50-d avg
1.62
200-d avg
3.97
1y target
39.00

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for BVXV has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-8.43 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -51.9×
FY 2013: -7.0×FY 2014: -8.2×FY 2015: -4.0×FY 2016: -4.7×FY 2017: -2.8×FY 2018: -5.0×FY 2019: -2.1×FY 2020: 14.6×FY 2021: -2.0×FY 2022: -51.9×
FY 2013 5y median -2.1× FY 2022
P/S 0.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2013 5y median 0.0× FY 2022
P/B -15.3×
FY 2013: 2.4×FY 2014: 3.8×FY 2015: 1.2×FY 2016: 1.7×FY 2017: 1.7×FY 2018: -14.1×FY 2019: -4.0×FY 2020: -22.0×FY 2021: 4.4×FY 2022: -15.3×
FY 2013 5y median -14.1× FY 2022
P/FCF -3.3×
FY 2013: -12.9×FY 2014: -8.3×FY 2015: -3.9×FY 2016: -4.5×FY 2017: -6.6×FY 2018: -1.4×FY 2019: -3.1×FY 2020: -1.3×FY 2021: -4.1×FY 2022: -3.3×
FY 2013 5y median -3.1× FY 2022
EV/EBITDA -3.3×
FY 2013: -5.6×FY 2014: -7.2×FY 2015: -0.7×FY 2016: -2.4×FY 2017: -2.0×FY 2018: -6.2×FY 2019: -3.5×FY 2020: 19.9×FY 2021: -4.4×FY 2022: -3.3×
FY 2013 5y median -3.5× FY 2022
EV/Sales 0.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2013 5y median 0.0× FY 2022
FCF Yield -30.1%
FY 2013: -7.8%FY 2014: -12.0%FY 2015: -25.5%FY 2016: -22.4%FY 2017: -15.1%FY 2018: -69.0%FY 2019: -32.3%FY 2020: -78.8%FY 2021: -24.3%FY 2022: -30.1%
FY 2013 5y median -32.3% FY 2022

Profitability

Gross Margin 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
ROE 30.2%
FY 2013: -33.5%FY 2014: -46.8%FY 2015: -30.4%FY 2016: -35.9%FY 2017: -61.4%FY 2018: 281.0%FY 2019: 190.8%FY 2020: -150.1%FY 2021: -217.8%FY 2022: 30.2%
FY 2013 5y median 30.2% FY 2022
ROIC -4.0%
FY 2013: -31.8%FY 2014: -48.9%FY 2015: -28.5%FY 2016: -41.2%FY 2017: -31.6%FY 2018: -91.7%FY 2019: -80.4%FY 2020: -30.6%FY 2021: -37.4%FY 2022: -4.0%
FY 2013 5y median -37.4% FY 2022
ROA -2.0%
FY 2013: -31.1%FY 2014: -42.1%FY 2015: -24.7%FY 2016: -30.5%FY 2017: -42.3%FY 2018: -82.9%FY 2019: -107.2%FY 2020: 38.5%FY 2021: -51.0%FY 2022: -2.0%
FY 2013 5y median -51.0% FY 2022

Growth (YoY)

Revenue 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 FY 2022
Operating Income 68.2%
FY 2013: 16.3%FY 2014: -6.6%FY 2015: -38.8%FY 2016: -5.3%FY 2017: -98.8%FY 2018: 13.5%FY 2019: -282.9%FY 2020: 101.3%FY 2021: -3448.9%FY 2022: 68.2%
FY 2013 FY 2022
EPS (diluted) 99.4%
FY 2013: 13.9%FY 2014: 3.4%FY 2015: -62.7%FY 2016: 29.7%FY 2017: -152.9%FY 2018: 48.2%FY 2019: -326.4%FY 2020: 104.0%FY 2021: -685.4%FY 2022: 99.4%
FY 2013 FY 2022
Free Cash Flow 67.5%
FY 2013: 39.8%FY 2014: -72.7%FY 2015: -35.5%FY 2016: 6.1%FY 2017: -50.5%FY 2018: -455.9%FY 2019: -4.4%FY 2020: 6.9%FY 2021: 68.3%FY 2022: 67.5%
FY 2013 FY 2022

Financial Health

Current Ratio 6.1×
FY 2013: 11.4×FY 2014: 7.0×FY 2015: 21.7×FY 2016: 19.0×FY 2017: 10.9×FY 2018: 3.5×FY 2019: 3.9×FY 2020: 0.2×FY 2021: 7.6×FY 2022: 6.1×
FY 2013 5y median 3.9× FY 2022
Quick Ratio 6.1×
FY 2013: 11.4×FY 2014: 7.0×FY 2015: 21.7×FY 2016: 19.0×FY 2017: 10.9×FY 2018: 3.6×FY 2019: 3.9×FY 2020: 0.2×FY 2021: 7.6×FY 2022: 6.1×
FY 2013 5y median 3.9× FY 2022
Debt / Equity -12.2×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: -3.0×FY 2019: -2.0×FY 2020: -4.6×FY 2021: 3.0×FY 2022: -12.2×
FY 2013 5y median -3.0× FY 2022
Net Debt / EBITDA -0.7×
FY 2013: 2.6×FY 2014: 1.3×FY 2015: 3.1×FY 2016: 1.4×FY 2017: 5.8×FY 2018: -0.2×FY 2019: -0.6×FY 2020: 3.0×FY 2021: -0.6×FY 2022: -0.7×
FY 2013 5y median -0.6× FY 2022
Interest Coverage 0.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: -5.7×FY 2019: -5.3×FY 2020: 0.2×FY 2021: -3.2×FY 2022: 0.0×
FY 2013 5y median -3.2× FY 2022

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31